Health  Vol.8 No.1 , January 2016
Comparison of the Length of Stay and Medical Expenditures among Japanese Hospitals for Type 2 Diabetes Treatments: The Box-Cox Transformation Model under Heteroscedasticity
Abstract: In this paper, we analyzed length of stay (LOS) in hospitals and medical expenditures for type 2 diabetes patients. LOS was analyzed by the power Box-Cox transformation model when variances differed among hospitals. We proposed a new test and consistent estimator. We rejected the ho-moscedasticity of variances among hospitals, and then analyzed the LOS of 12,666 type 2 diabetes patients hospitalized for regular medical treatments collected from 60 general hospitals in Japan. The variables found to affect LOS were age, number of comorbidities and complications, introduced by another hospital, one-week hospitalization, 2010 revision, specific-hospitalization-period (SHP), and principal diseases E11.5, E11.6 and E11.7. There were surprisingly large differences in ALOS among hospitals even after eliminating the influence of characteristics and conditions of patients. We then analyzed daily medical expenditure (DME) by the ordinary least squares methods. The variables that affected DME were LOS, number of comorbidities and complications, acute hospitalization, hospital’s own outpatient, season, introduced by another hospital, one-week hospitalization, 2010 revision, SHP, time trend, and principal diseases E11.2, E11.4 and E117. The DME did not decrease after the SHP. After eliminating the influences of characteristics and conditions of patients, the differences among hospitals were relatively small, 12% of the overall average. LOS is the main determinant of medical expenditures, and new incentives to reduce LOS are needed to control Japanese medical expenditures. Since at least 99% of patients require medical care after leaving the hospital, systems that take proper care of patients for long periods of time after hospitalization are absolutely necessary for efficient treatment of diabetes.
Cite this paper: Nawata, K. and Kawabuchi, K. (2016) Comparison of the Length of Stay and Medical Expenditures among Japanese Hospitals for Type 2 Diabetes Treatments: The Box-Cox Transformation Model under Heteroscedasticity. Health, 8, 49-63. doi: 10.4236/health.2016.81007.

[1]   Ministry of Health, Labour and Welfare (2015) Hesiei 25 nendo kokumin iryouhi (National Medical Expenditures, Fiscal Year 2013, in Japanese).

[2]   Ministry of Finance (2015) Kuni oyobi chihou no chouki saimu sandaka (Long-Term Deficits of the Central and Local Governments, in Japanese).

[3]   International Diabetes Foundation (2014) DIABETES ATLAS. 6th Edition.

[4]   American Diabetes Association ADA (2015) Complications.

[5]   Alva, M., Gray, A., Mihayalov, B. and Clarke, P. (2014) The Effect of Diabetes Complications on Health-Related Quality of Life: The Longitudinal Data to Address Patient Heterogeneity. Health Economics, 23, 487-500.

[6]   Public Health Agency of Canada (2015) The Health and Economic Impacts of Diabetes. Chapter 3, Diabetes in Canada: Facts from a Public Health Perspective.

[7]   Lesniowska, J., Schubert, A., Wojna, M., et al. (2014) Costs of Diabetes and Its Complications in Poland. European Journal of Health Economics, 15, 653-660.

[8]   Chereches, R.M., Litan, C.M., Zlati, A.M. and Bloom, J.R. (2012) Does Co-Morbid Depression Impact Diabetes Related Costs? Evidence from a Cross-Sectional Survey in a Low-Income Country. Journal of Mental Health Policy and Economics, 15, 127-138.

[9]   Yeaw, J. (2014) Direct Medical Costs for Complications among Children and Adults with Diabetes in the US Commercial Setting. Applied Health Economics and Health Policy, 12, 219-230.

[10]   Zhuo X., Zhang, P., Barker, L., et al. (2014) The Lifetime Cost of Diabetes and Its implications for Diabetes Prevention. Diabetes Care, 37, 2557-2564.

[11]   Condliffe, S., Link, C.R., Parasuraman, S. and Pollack, M.F. (2013) The Effects of Hypertension and Obesity on Total Health-Care Expenditures of Diabetes Patients in the United States. Applied Economics Letters, 20, 649-652.

[12]   Yesudian, C.A.K., Grepstad, M., Visintin, E. and Ferrario, A. (2014) The Economic Burden of Diabetes in India: A Review of the Literature. Globalization and Health, 10, 80.

[13]   Dall, T.M., Zhang, Y., Chen, Y.J., Quick, W.W., Yang, W.G. and Fogli, J. (2010) The Economic Burden of Diabetes. Health Affairs, 29, 297-303.

[14]   American Diabetes Association (ADA) (2013) Economic Costs of Diabetes in the U.S. in 2012. Diabetes Care, 36, 1033-1046.

[15]   Minor, T. (2011) The Effect of Diabetes on Female Labor Force Decision: New Evidence from the National Health Interview Survey. Health Economics, 20, 1468-1486.

[16]   Minor, T. (2013) An Investigation into the Effect of Type I and Type II Diabetes Duration on Employment and Wages. Economics and Human Biology, 11, 534-544.

[17]   Sorensen, J. and Ploug, U.J. (2013) The Cost of Diabetes-Related Complications: Registry-Based Analysis of Days Absent from Work. Economic Research International, 2013, Article ID: 618039.

[18]   Liu, X. and Zhub, C. (2014) Will Knowing Diabetes Affect Labor Income? Evidence from a Natural Experiment. Economics Letters, 124, 74-78.

[19]   Seuring, T., Goryakin, Y. and Suhrcke, M. (2015) The Impact of Diabetes on Employment in Mexico. Economics and Human Biology, 18, 85-100.

[20]   DPC Evaluation Division, Central Social Insurance Medical Council, Ministry of Health, Labour and Welfare (2015) DPC taishou byouin, junnbi byouin no kibo (heisei 27 nen 4 gatsu 1 nichi) mikomi [Estimated Numbers of DPC Hospitals and Preparing Hospitals by Sizes of Hospitals as of April 1st, 2015]. (In Japanese)

[21]   IDF (2014) About Diabetes.

[22]   ADA (2015) Diabetes Basic.

[23]   Nawata, K. and Kawabuchi, K. (2015) Evaluation of Length of Hospital Stay Joining Educational Programs for Type 2 Diabetes Mellitus Patients: Can We Control Medical Costs in Japan? Health, 7, 256-269.

[24]   Nawata, K. and Kawabuchi, K. (2015) Financial Sustainability of the Japanese Medical Payment System: Analysis of the Japanese Medical Expenditure for Educational Hospitalization of Patients with Type 2 Diabetes. Health 7, 1007-1021.

[25]   Box, G.E.P. and Cox, D.R. (1964) An Analysis of Transfor-mation. Journal of the Royal Statistical Society B, 26, 211-252.

[26]   Showalter, M.H. (1994) A Monte Carlo Investigation of the Box-Cox Model and a Nonlinear Least Squares Alternative. Review of Economics and Statistics, 76, 560-570.

[27]   Nawata, K. (2015) Robust Estimation Based on the Third-Moment Restriction of the Error Terms for the Box-Cox Transformation Model: An Estimator Consistent under Heteroscedasticity. Economics Bulletin, 3, 1056-1064.

[28]   Heinze, G., Hronsky, M., Reichardt, B., Baumgartel, C., Müllner, M., Bucsics, A. and Winkelmayer, W.C. (2015) Potential Savings in Prescription Drug Costs for Hypertension, Hyperlipidemia, and Diabetes Mellitus by Equivalent Drug Substitution in Austria: A Nationwide Cohort Study. Applied Health Economics and Policy, 13, 193-205.

[29]   Watson, P., Preston, L., Squires, H., Chilcott, J. and Brennan, A. (2014) Modelling the Economics of Type 2 Diabetes Mellitus Prevention: A Literature Review of Methods. Applied Health Economics and Health Policy, 12, 239-253.

[30]   Sittig, D.T., Friedel, H. and Wasem, J. (2015) Prevalence and Treatment Costs of Type 2 Diabetes in Germany and the Effects of Social and Demographical Differences. European Journal of Health Economics, 16, 305-311.

[31]   Bickel, P.J. and Doksum, K.A. (1981) An Analysis of Transformations Revisited. Journal of the American Statistical Association, 76, 296-311.

[32]   Nawata, K. (2013) A New Estimator of the Box-Cox Transformation Model Using Moment Conditions. Economics Bulletin, 33, 2287-2297.

[33]   Hausman, J. (1978) Specification Tests in Econometrics. Econometrica, 46, 1251-1272.

[34]   White, H. (1980) A Heteroskedasticity-Consistent Covariance Matrix and Direct Test for Heteroskedasticity. Econo- metrica, 48, 817-838.

[35]   Kantarevic, J. and Kralj, B. (2013) Link between Pay for Performance Incentives and Physician Payment Mechanisms: Evidence from Diabetes Management Incentive in Ontario. Health Economics, 22, 1417-1439.

[36]   Iezzi, E., Bruni, M.L. and Ugolini, C. (2014) The Role of GP’s Compensation Schemes in Diabetes Care: Evidence from Panel Data. Journal of Health Economics, 34, 104-120.

[37]   Wilke, T., Groth, A., Mueller, S., Reese, D., Linder, R., Ahrens, S. and Verheyen, F. (2013) How to Use Pharmacy Claims Data to Measure Patient Nonadherence? The Example of Oral Diabetics in Therapy of Type 2 Diabetes Mellitus. European Journal of Health Economics, 14, 551-568.

[38]   Dilla, T., Valladares, A., Nicolay, C., Salvador, J., Reviriego, J. and Costi, M. (2012) Healthcare Costs Associated with Change in Body Mass Index in Patients with Type 2 Diabetes Mellitus in Spain: The ECOBIM Study. Applied Health Economics and Policy, 10, 417-430.

[39]   Slade, A.N. (2012) Health Investment Decisions in Response to Diabetes Information in Older Americans. Journal of Health Economics, 31, 502-520.

[40]   Daim, T.U., Basoglu, N. and Topacan, U. (2013) Adoption of Health Information Technologies: The Case of a Wireless Monitor for Diabetes and Obesity Patients. Technology Analysis & Strategic Management, 25, 923-938.

[41]   Mehrotra, S. and Kim, K. (2011) Outcome Based State Budget Allocation for Diabetes Prevention Programs Using Multi-Criteria Optimization with Robust Weights. Health Care Management Science, 14, 324-337.

[42]   Condliffe, S. and Link, C.R. (2014) Racial Differences in the Effects of Hypertension and Obesity on Health Expenditures by Diabetes Patients in the US. Applied Economics Letters, 21, 280-283.

[43]   Phelps, K.W., Hodgson, J.L. and Lamson, A.L. (2012) Satisfaction with Life and Psychosocial Factors among Underserved Minorities with Type 2 Diabetes. Social Indicators Research, 106, 359-370.

[44]   Salois, M.J. (2012) Obesity and Diabetes, the Built Environment, and the “Local” Food Economy in the United States, 2007. Economics and Human Biology, 10, 35-42.

[45]   Pan, X. and Ward, R.M. (2015) Self-Management and Self-Rated Health among Middle-Aged and Older Adults with Type 2 Diabetes in China: A Structural Equation Model. Social Indicators Research, 120, 247-260.

[46]   Eggleston, K.N., Shah, N.D., Smith, S.A., Berndt, E.R. and Newhouse, J.P. (2011) Quality Adjustment for Health Care Spending on Chronic Disease: Evidence from Diabetes Treatment, 1999-2009. American Economic Review: Papers & Proceedings, 101, 206-211.

[47]   Thurecht, L. and Brown, L. (2011) Economic Modelling of the Prevention of Type 2 Diabetes in Australia—The Diabetes Model. International Journal of Microsimulation, 4, 71-80.

[48]   Kruger, J. and Brennan, A. (2013) The Cost of Type 1 Diabetes Mellitus in the United Kingdom: A Review of Cost-of-Illness Studies. European Journal of Health Economics, 14, 886-899.